“I think the China business coming from a double-digit growth trajectory through a significant dip, and we don’t expect it to go back to double digits, we expect it over time to go to maybe mid singles, so more in line with what we see in other developed markets.”

In context

“has been sluggish for a few years, which I think is why there’s been so many questions about the effect of annualizing. You’re not the only company to see slower results in China, so I wonder if you could just maybe comment on clearly there are macro dynamics in the market versus micro parts of your portfolio which specifically need some work. SK-II has been well covered by this point, so perhaps you can speak to some other businesses that are performing in line with your expectations or not, so that we can have a bit more of a portfolio view on why the annualization should deliver the outcomes you’re expecting into the back half of the year. Sorry for another question on China, but it felt important. Thanks. Andre Schulten: Hey Chris. I’ll start and Jon will add. Let me start by saying, I think the China business coming from a double-digit growth trajectory through a significant dip, and we don’t expect it to go back to double digits, we expect it over time to go to maybe mid singles, so more in line with what we see in other developed markets. For sure, we don’t expect the return to the growth rates that we saw pre-COVID. Many of the effects specifically in China, SK-II, I think the run rate is now stable, so we’re already seeing the run rate in terms of absolute volume and absolute dollar sale flattening. What’s not yet there is the base period in line with those run rates, so unless we see a significant run rate reduction, that gives us confidence that the annualization would take place. Maybe other point of confidence here, the toughest category to compete in, in China right now is probably baby care. Birth rates are down 15% to 25% depending on how you define the market, and we’ve been able--the team has been able to grow sales 6% and grow share in the market. Why? Because the portfolio and the innovation the team designed”